An extensive international study finds that Janus kinase inhibitors do not increase cardiovascular risk compared to TNF inhibitors in rheumatoid arthritis patients, offering reassurance for short-term use across diverse...
Most Recent Articles
Childhood Trauma and Its Impact on Substance Use and Cardiovascular Health in Adolescence: A Longitudinal Study in Brazil
A Brazilian cohort study links childhood trauma to increased adolescent substance use and unexpectedly lower heart rate and blood pressure, revealing complex pathways between early adversity and long-term cardiovascular health.
Innovative CMR Model Predicts Functional Heart Age in Healthy and High-Risk Populations
A new CMR-based model accurately estimates functional heart age, revealing early cardiovascular risk in high-risk patients and offering a promising tool for preventive care before symptoms appear.
Targeting COMP: A Key Mechanism in Collagen Accumulation in Oral Submucous Fibrosis
New research identifies COMP as a central driver of collagen buildup in oral submucous fibrosis, suggesting that targeting this protein may offer a promising strategy to prevent or reverse disease progression.
Limited Access to Cardioprotective Medications in Medicaid: A Cross-National Study
Many Medicaid enrollees across the U.S. still face restricted access to cardioprotective drugs like GLP-1 RAs and SGLT2 inhibitors, with wide disparities in availability between states and plan types.